Cohen & Steers, Inc.
NYSE:CNSAsset Management
+$0.63 today
- Market cap
- $3.45B
- Beta
- 1.23
- P/E (TTM)
- 24.8
- EPS (TTM)
- $3.03
- Dividend yield
- 3.44%
Volume 0.39M
Average 0.32M
CNS Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Cohen & Steers, Inc.NYSE: CNS
Accounts Receivables · Q2 FY2026 · quarter ended Jun 2026
Accounts receivables turns positive
Q2 FY2026 accounts receivables was $5.2M, compared with -$4.17M a year earlier. Trailing-twelve-month accounts receivables was -$11.21M.
Context
- Accounts receivables amounted to 3.2% of revenue in FY2025, down 2.3 pp from a year earlier.
- Accounts receivables increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly accounts receivables holds near $5.2M or moves back toward the trailing-twelve-month quarterly average of -$2.8M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2025
- (18.02M) USD
- Year-over-year change
- +36.3%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (18.02M) | +36.3% |
| FY2024 | 2024-12-31 | (28.31M) | -602.3% |
| FY2023 | 2023-12-31 | (4.03M) | -128.4% |
| FY2022 | 2022-12-31 | 14.2M | +186.6% |
| FY2021 | 2021-12-31 | (16.38M) | — |
Accounts Receivables vs competitors
How CNS compares with its peers on the latest reported figures
- CNS's LTM Jun 2026 accounts receivables of $11.21M is the 5th largest of the 10 companies compared; the peer median is $1.72M.
- Its year-over-year change of -74.4% is the 7th highest of 8, against a peer median of -4.4%.
- Accounts receivables amounts to 1.9% of revenue for CNS, versus a peer median of 0.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $165M | -137.8% | — | 18.4% | |
| LTM Jun 2026 | $93.58M | -1.8% | -4.4% | 20.2% | |
| LTM Jun 2026 | $40.41M | -29.4% | — | 2.6% | |
| LTM Sep 2026 | $12.94M | +468.4% | — | 1.9% | |
| LTM Jun 2026 | $11.21M | -74.4% | — | 1.9% | |
| LTM Sep 2026 | $9.7M | +12.4% | — | 0.8% | |
| LTM Jun 2026 | $4.25M | -4.4% | — | 0.2% | |
| LTM Jun 2026 | $1.72M | -57.0% | -27.9% | 0.3% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding CNS) | $1.72M | -4.4% | -16.1% | 0.8% | |
Competitors are the stored peer set for CNS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 226.15M | 149.49M | 129.05M | 162.79M | 144.87M |
| Depreciation & Amortization | 16.03M | 5.67M | 5.14M | 11.17M | 11.71M |
| Deferred Income Tax | 104K | (1.2M) | 537K | (297K) | 561K |
| Stock-Based Compensation | 40.46M | 49.35M | 44.47M | 52.3M | 45.96M |
| Change in Working Capital | (23.04M) | (180M) | (22.26M) | (118.58M) | (15.74M) |
| Accounts Receivables | (16.38M) | 14.2M | (4.03M) | (28.31M) | (18.02M) |
| Inventory | (2.89M) | 0 | 0 | 0 | 0 |
| Accounts Payables | 2.89M | 0 | 1.83M | 0 | 5.13M |
| Other Working Capital | (6.66M) | (194.2M) | (20.06M) | (90.27M) | (2.85M) |
| Other Non-Cash Items | (16.81M) | 38.38M | 15.02M | (10.7M) | (307.81M) |
| Operating Cash Flow | 242.9M | 61.68M | 171.96M | 96.69M | (120.44M) |
| Capital Expenditures | (2.7M) | (4.22M) | (56.99M) | (11.65M) | (5.98M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (54.04M) | (145.35M) | (169.4M) | (417.46M) | (383.42M) |
| Sales of Investments | 104.39M | 146.71M | 111.61M | 309.4M | 397.75M |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | 47.65M | (2.86M) | (114.78M) | (119.71M) | 8.36M |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 1M | 1.04M | 1.06M | 68.46M | 961K |
| Common Stock Repurchased | (22.59M) | (26.82M) | (21.54M) | (21.11M) | (28.42M) |
| Dividends Paid | (147.56M) | (107.35M) | (112.45M) | (119.18M) | (126.92M) |
| Other Financing Activities | 24.72M | 142.1M | 13.87M | 89.99M | 228.22M |
| Financing Cash Flow | (145.43M) | 8.98M | (119.05M) | 18.17M | 73.84M |
| Effect of Forex Changes | (999K) | (4.44M) | 2.76M | (1.59M) | 1.69M |
| Net Change in Cash | 144.12M | 63.36M | (59.11M) | (6.44M) | (36.56M) |
| Free Cash Flow | 240.21M | 57.46M | 114.98M | 85.04M | (126.42M) |
Cohen & Steers, Inc.
NYSE:CNS
Intrinsic Alpha fair value
Locked
Current Price
$67.04
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.